Developer docs
API playgroundTry for free, no card

Search company profiles

Cryoport

Full company profile

uuid02lye8a

Namestring
Cryoport
Legal namestring
Cryoport Systems, LLC
Websiteurl
cryoportinc.com
Company typeenum
Public
Founded yearint
1990
Descriptiontext

Cryoport, Inc. (NASDAQ: CYRX) is a global provider of temperature-controlled supply chain solutions for the Life Sciences industry, headquartered in Brentwood, Tennessee with manufacturing in Brea, California and operations across 15+ locations in the Americas, EMEA, and APAC. The company operates three business units — Cryoport Systems (integrated temperature-controlled logistics), MVE Biological Solutions (cryogenic storage and shipper systems, with over 50 years of brand heritage), and CRYOGENE (U.S.-based medical biorepository for biological specimen storage). Its product portfolio centers on reusable cryogenic dry vapor shippers (AR1000, DG1000, DS650) capable of maintaining temperatures below -150°C for up to 10-16 days, plus the Advanced Therapy Shippers (ATS) line purpose-built for cell and gene therapies and the Cryoport Elite Ultra Cold Shipper for dry-ice-based transport. The company holds IATA dangerous goods certifications, multiple patents on cryogenic container technology, and operates the Cryoportal.com logistics management platform.

The business model combines three revenue streams: hardware sales of reusable cryogenic shippers ($685-$1,095 per unit), recurring cycle-fee leasing of shipper units on 15-day Standard Cycles under multi-year contracts, and managed biostorage and sample processing services through CRYOGENE. Go-to-market is sales-led, combining a direct enterprise sales team with third-party distributors and agents (Liquide, SCA Thermosafe, exclusive South American agent CryoPort Systems Ltda.). The customer base spans biopharmaceutical and life sciences companies (primary), animal husbandry, reproductive medicine/IVF, universities and research institutions, and government agencies. The company was originally incorporated in Nevada in 1990 as G.T.5-Limited, acquired CryoPort Systems, Inc. via a share exchange in March 2005, and adopted the CryoPort name and current business focus. Leadership is anchored by Chairman, President, and CEO Jerrell W. Shelton (appointed November 2012), with a board that includes representation from Blackstone's healthcare team.

Short descriptiontext

Cryoport (NASDAQ: CYRX) provides temperature-controlled supply chain and cryogenic storage solutions for the Life Sciences industry, serving biopharmaceutical, animal husbandry, and reproductive medicine companies across 15+ global locations with 700+ employees.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBrentwood, United States
HQ citystring
Brentwood
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cryogenic shipping containers, temperature-controlled logistics, life sciences supply chain, biostorage biorepository services, cell and gene therapy transport
Industry6 codes
PRIMARYHLAGAGAK
Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAGAMAB
Cryogenic Logistics (LN2 Dry Shippers, -150°C)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYTLADAHAJ
Cryogenic / Ultra-Low Temperature Transport (e.g., dry ice, LN2)
Transportation & Logistics/Freight Transportation (Air, Maritime, Rail, Trucking)/Refrigerated & Temperature-Controlled Freight Transport
SECONDARYHLAGAIAJ
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)
SECONDARYHLAAAJAN
Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYTLAIAIAK
Cryogenic & Ultra-Low Temperature Logistics (-80°C, LN2 Dry Shipper)
NAICS code2 codes
  • Air-Conditioning and Warm Air Heating Equipment and Commercial and Industrial Refrigeration Equipment Manufacturing333415
  • Refrigerated Warehousing and Storage493120
SIC code1 code
  • Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip3585
Product category
Cryogenic Life Sciences Logistics and Storage
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Cryogenic Shipping Container Sales
TypeHardware Sales
Description

Sale of reusable cryogenic dry vapor shippers (AR1000, DG1000, DS650) and related products

cryoportinc.com
2Shipper Unit Leasing Services
TypeSubscription Recurring
Description

Cycle Fee-based leasing of shipper units with Standard Cycles of 15 days. Customers pay lease rate fees per Standard Cycle with additional fees for extended use or non-return of units.

cryoportinc.com
3Biostorage and Sample Processing
TypeManaged Services
Description

Services provided through CRYOGENE biorepository for secure storage of biological research specimens and associated supplies

cryoportinc.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details3 tiers
1Standard Cycle Fee - 15-day lease period
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Initial Cycle Fee applicable starting the day Shipper Unit ships from Cryoport facility. Additional Cycle Fee applies if unit not returned within Standard Cycle. Extended cycles available in 5-day increments at additional 33.33% fee.

cryoportinc.com
2Cryogenic Storage Systems
ModelOne time/ perpetual licenseBilling cadenceOne time/ perpetual license
Notes

Reusable cryogenic shippers priced from $685 to $1,095 per unit depending on model (AR1000, DG1000, DS650)

cryoportinc.com
3Disposable/One-Way Shippers (Future)
ModelOne time/ perpetual licenseBilling cadenceOne time/ perpetual license
Notes

Proposed disposable shippers expected to range from $50 to $175 per use depending on size

cryoportinc.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Cryoport Systems
Description

Market leader in globally integrated temperature-controlled supply chain support for the Life Sciences industry.

cryoportinc.com
+2 more records
Core offering1 text field

Cryoport, Inc. designs, manufactures, and leases temperature-controlled cryogenic shipping containers and storage systems for the Life Sciences industry through its Cryoport Systems, MVE Biological Solutions, and CRYOGENE business units. It also provides biostorage, sample processing, and temperature-controlled logistics support for biopharmaceutical, animal husbandry, and reproductive medicine customers, with cryogenic shippers that maintain temperatures of -150°C or below for 10-16 days and are IATA-certified for dangerous goods transport.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Maintain cryogenic temperatures of -150°C or less for up to 10 days (functional hold time in shipping use) and up to 16 days (maximum guaranteed under static conditions)
Product overview1 text field

Cryoport offers a comprehensive portfolio of temperature-controlled supply chain solutions for the Life Sciences industry, organized across three primary business units: Cryoport Systems (temperature-controlled logistics), MVE Biological Solutions (cryogenic storage and shipper systems), and CRYOGENE (biorepository services). The product portfolio includes Advanced Therapy Shippers™ for cell and gene therapy transport, the Cryoport Elite™ Ultra Cold Shipper for dry ice-based shipping, and reusable cryogenic dry vapor shippers including the AR1000, DG1000, and DS650 models. Customers interact with the platform through Cryoportal.com for order processing and shipment management. The company operates across 15+ global locations serving biopharmaceutical, animal husbandry, and reproductive medicine companies.

Product and service10 records
1Cryoport Systems
CategoryTemperature-controlled logistics business unit
Description

Market leader in globally integrated temperature-controlled supply chain support for the Life Sciences industry, providing cryogenic shipping solutions for biopharmaceutical, animal husbandry, and reproductive medicine customers.

2MVE Biological Solutions
CategoryCryogenic storage systems business unit
Description

Cryogenic storage and shipper systems for the Life Sciences industry, with over half a century of experience as the preferred choice for cryogenic solutions, offered under the MVE brand.

3CRYOGENE
CategoryBiostorage and sample processing business unit
Description

Leading U.S.-based medical biorepository focused on secure storage of biological research specimens and associated supplies, serving research institutions and life sciences customers.

4Advanced Therapy Shippers (ATS)
CategoryCryogenic shipping containers
Description

Temperature-controlled shipping containers specifically designed for transporting cell and gene therapies containing human clinical and/or commercial product, compliant with IATA classifications for Biological Substance, Category B and related materials. For biopharmaceutical customers developing and commercializing advanced therapies.

5Cryoport Elite Ultra Cold Shipper
CategoryUltra-cold dry ice shipping containers
Description

Dry ice-based ultra cold shipping container for temperature-sensitive biological materials, with specific requirements for dry ice removal prior to return. For Life Sciences customers requiring ultra-cold transport applications.

6AR1000
CategoryReusable cryogenic dry vapor shippers
Description

Reusable cryogenic dry vapor shipper utilized primarily in veterinary and human assisted reproduction markets, capable of maintaining temperatures below -150°C for up to 10 days. Priced from $685 to $1,095 per unit.

7DG1000
CategoryReusable cryogenic dry vapor shippers
Description

Reusable cryogenic shipper designed for shipping biological materials classified as dangerous goods by IATA standards, IATA certified for shipment of Class 6.2 Dangerous Goods under Packing Instruction 602. Priced from $685 to $1,095 per unit.

8DS650
CategoryReusable cryogenic dry vapor shippers
Description

Reusable cryogenic shipper for shipment of specimens for diagnosis, treatment or evaluation of disease, conforming to IATA Packing Instruction 650 packaging standards. Priced from $685 to $1,095 per unit.

9Shipper Unit Leasing Services
CategoryShipper leasing services
Description

Cycle Fee-based leasing of Cryoport shipper units with Standard Cycles of 15 days. Customers pay lease rate fees per Standard Cycle, with additional Cycle Fees for units not returned within the Standard Cycle and extended cycles available in 5-day increments at an additional 33.33% fee. For Life Sciences customers running clinical and commercial cryogenic logistics.

10Biostorage and Sample Processing
CategoryBiorepository and sample processing services
Description

Biostorage and sample processing services provided through the CRYOGENE biorepository for the secure storage of biological research specimens and associated supplies. For research institutions, universities, and biopharmaceutical customers.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1CryoPort Systems Ltda.
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive South American sales agent based in Sao Paulo, Brazil. Provides 17% commission for all sales in South American countries under a ten-year agreement expiring August 9, 2011.

ir.cryoportinc.com
2Liquide
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Third-party reseller relationship for Cryoport products

ir.cryoportinc.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Third-party reseller relationship for Cryoport products

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Vineti
TypeEmerging player
Description

Vineti provides a cloud-based platform for cell & gene therapy supply chain management, including chain of custody and patient scheduling. While focused on software rather than physical cryogenic logistics, it addresses similar cold chain orchestration challenges that Cryoport's Cryoportal.com platform targets.

TypeEmerging player
Description

Sartorius provides bioprocessing equipment and consumables for cell & gene therapy manufacturing, including some cryopreservation and cold chain-adjacent products. While primarily a bioprocessing-focused company, it offers storage and handling technologies that intersect with Cryoport's biopharma manufacturing services.

TypeDirect peer
Description

Azenta provides biological sample storage, biorepository services, and cold chain logistics for the life sciences industry. Its sample management and biorepository offerings directly compete with Cryoport's CRYOGENE unit, and the company has expanded into temperature-controlled transport services.

TypeEmerging player
Description

BioLife Solutions provides biopreservation tools, cryopreservation media, and cold chain shipping products for the cell & gene therapy industry. While focused more on consumables and storage media than full-service logistics, it competes with Cryoport's CRYOGENE biorepository and adjacent cryopreservation offerings.

TypeBroad incumbent
Description

Cytiva is a global life sciences tools and bioprocessing provider owned by Danaher, offering products for cell therapy manufacturing including cryopreservation and cold storage solutions. As a broad incumbent, it competes with Cryoport's offerings to cell & gene therapy developers through its comprehensive bioprocessing portfolio.

TypeDirect peer
Description

Marken is a global specialty courier for the life sciences industry, offering temperature-controlled and cryogenic logistics for clinical trials and cell & gene therapies. As a subsidiary of UPS Healthcare, it directly competes with Cryoport Systems in the same biopharma cold chain logistics market with comparable service offerings.

TypeDirect peer
Description

World Courier is a global specialty logistics provider serving the biopharmaceutical industry with temperature-controlled and cryogenic shipping capabilities. Owned by Cencora (formerly AmerisourceBergen), it competes directly with Cryoport Systems for clinical trial specimen transport and commercial therapy distribution.

TypeBroad incumbent
Description

Thermo Fisher Scientific is a diversified life sciences tools and services giant offering cryogenic storage equipment through its laboratory products division. While it does not specialize in cryogenic logistics like Cryoport, it competes in adjacent product categories including biological storage systems and biopreservation consumables.

TypeDirect peer
Description

QuickSTAT is a global specialty courier specializing in time-sensitive and temperature-controlled logistics for clinical trials, biological samples, and cell therapies. Now part of Kuehne+Nagel, it competes directly with Cryoport in life sciences cold chain logistics with similar target customers.

10Hyperion Logistics (formerly QuickSTAT competitor, Spanish pharma courier)
TypeRegional player
Description

Hyperion Logistics is a European specialty courier offering temperature-controlled and time-critical logistics for clinical trials and biopharmaceuticals. It competes with Cryoport in the EMEA region for life sciences cold chain services with comparable cryogenic handling capabilities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cryoport

Cryogenic Life Sciences Logistics and Storagecryoportinc.com

Cryoport (NASDAQ: CYRX) provides temperature-controlled supply chain and cryogenic storage solutions for the Life Sciences industry, serving biopharmaceutical, animal husbandry, and reproductive medicine companies across 15+ global locations with 700+ employees.

What Cryoport does

Cryoport, Inc. (NASDAQ: CYRX) is a global provider of temperature-controlled supply chain solutions for the Life Sciences industry, headquartered in Brentwood, Tennessee with manufacturing in Brea, California and operations across 15+ locations in the Americas, EMEA, and APAC. The company operates three business units — Cryoport Systems (integrated temperature-controlled logistics), MVE Biological Solutions (cryogenic storage and shipper systems, with over 50 years of brand heritage), and CRYOGENE (U.S.-based medical biorepository for biological specimen storage). Its product portfolio centers on reusable cryogenic dry vapor shippers (AR1000, DG1000, DS650) capable of maintaining temperatures below -150°C for up to 10-16 days, plus the Advanced Therapy Shippers (ATS) line purpose-built for cell and gene therapies and the Cryoport Elite Ultra Cold Shipper for dry-ice-based transport. The company holds IATA dangerous goods certifications, multiple patents on cryogenic container technology, and operates the Cryoportal.com logistics management platform.

The business model combines three revenue streams: hardware sales of reusable cryogenic shippers ($685-$1,095 per unit), recurring cycle-fee leasing of shipper units on 15-day Standard Cycles under multi-year contracts, and managed biostorage and sample processing services through CRYOGENE. Go-to-market is sales-led, combining a direct enterprise sales team with third-party distributors and agents (Liquide, SCA Thermosafe, exclusive South American agent CryoPort Systems Ltda.). The customer base spans biopharmaceutical and life sciences companies (primary), animal husbandry, reproductive medicine/IVF, universities and research institutions, and government agencies. The company was originally incorporated in Nevada in 1990 as G.T.5-Limited, acquired CryoPort Systems, Inc. via a share exchange in March 2005, and adopted the CryoPort name and current business focus. Leadership is anchored by Chairman, President, and CEO Jerrell W. Shelton (appointed November 2012), with a board that includes representation from Blackstone's healthcare team.

Cryoport firmographics

Firmographics
Name
Cryoport
Legal name
Cryoport Systems, LLC
Website
https://cryoportinc.com
Company type
Public
Founded year
1990
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Cryoport (NASDAQ: CYRX) provides temperature-controlled supply chain and cryogenic storage solutions for the Life Sciences industry, serving biopharmaceutical, animal husbandry, and reproductive medicine companies across 15+ global locations with 700+ employees.
Ownership category
akta.pro rank

Cryoport industry classification

Industry
Product category
Cryogenic Life Sciences Logistics and Storage
NAICS
Air-Conditioning and Warm Air Heating Equipment and Commercial and Industrial Refrigeration Equipment Manufacturing (333415), Refrigerated Warehousing and Storage (493120)
SIC
Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip (3585)
akta.pro industry
PRIMARYHLAGAGAK
Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAGAMAB
Cryogenic Logistics (LN2 Dry Shippers, -150°C)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYTLADAHAJ
Cryogenic / Ultra-Low Temperature Transport (e.g., dry ice, LN2)
Transportation & Logistics/Freight Transportation (Air, Maritime, Rail, Trucking)/Refrigerated & Temperature-Controlled Freight Transport
SECONDARYHLAGAIAJ
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)
SECONDARYHLAAAJAN
Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYTLAIAIAK
Cryogenic & Ultra-Low Temperature Logistics (-80°C, LN2 Dry Shipper)

Keywords

  • Cryogenic shipping containers
  • Temperature-controlled logistics
  • Life sciences supply chain
  • Biostorage biorepository services
  • Cell and gene therapy transport

Where Cryoport is headquartered

Location

Headquarters

HQ city
Brentwood
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Cryoport business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Cryogenic Shipping Container Sales: Sale of reusable cryogenic dry vapor shippers (AR1000, DG1000, DS650) and related products
  2. Shipper Unit Leasing Services: Cycle Fee-based leasing of shipper units with Standard Cycles of 15 days. Customers pay lease rate fees per Standard Cycle with additional fees for extended use or non-return of units.
  3. Biostorage and Sample Processing: Services provided through CRYOGENE biorepository for secure storage of biological research specimens and associated supplies

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractStandard Cycle Fee - 15-day lease period
One time/ perpetual licenseOne time/ perpetual licenseCryogenic Storage Systems
One time/ perpetual licenseOne time/ perpetual licenseDisposable/One-Way Shippers (Future)

Go-to-market motion1 record

Distribution channels5 records

Marketing channels2 records

Cryoport product offering

Product offering

Core offering

Cryoport, Inc. designs, manufactures, and leases temperature-controlled cryogenic shipping containers and storage systems for the Life Sciences industry through its Cryoport Systems, MVE Biological Solutions, and CRYOGENE business units. It also provides biostorage, sample processing, and temperature-controlled logistics support for biopharmaceutical, animal husbandry, and reproductive medicine customers, with cryogenic shippers that maintain temperatures of -150°C or below for 10-16 days and are IATA-certified for dangerous goods transport.

Product overview

Cryoport offers a comprehensive portfolio of temperature-controlled supply chain solutions for the Life Sciences industry, organized across three primary business units: Cryoport Systems (temperature-controlled logistics), MVE Biological Solutions (cryogenic storage and shipper systems), and CRYOGENE (biorepository services). The product portfolio includes Advanced Therapy Shippers™ for cell and gene therapy transport, the Cryoport Elite™ Ultra Cold Shipper for dry ice-based shipping, and reusable cryogenic dry vapor shippers including the AR1000, DG1000, and DS650 models. Customers interact with the platform through Cryoportal.com for order processing and shipment management. The company operates across 15+ global locations serving biopharmaceutical, animal husbandry, and reproductive medicine companies.

Differentiator

Problem solved

Functional benefit

Brands

  • Cryoport Systems: Market leader in globally integrated temperature-controlled supply chain support for the Life Sciences industry.
  • MVE Biological Solutions
  • CRYOGENE

Products and services

  • Cryoport Systems Market leader in globally integrated temperature-controlled supply chain support for the Life Sciences industry, providing cryogenic shipping solutions for biopharmaceutical, animal husbandry, and reproductive medicine customers.
  • MVE Biological Solutions Cryogenic storage and shipper systems for the Life Sciences industry, with over half a century of experience as the preferred choice for cryogenic solutions, offered under the MVE brand.
  • CRYOGENE Leading U.S.-based medical biorepository focused on secure storage of biological research specimens and associated supplies, serving research institutions and life sciences customers.
  • Advanced Therapy Shippers (ATS) Temperature-controlled shipping containers specifically designed for transporting cell and gene therapies containing human clinical and/or commercial product, compliant with IATA classifications for Biological Substance, Category B and related materials. For biopharmaceutical customers developing and commercializing advanced therapies.
  • Cryoport Elite Ultra Cold Shipper Dry ice-based ultra cold shipping container for temperature-sensitive biological materials, with specific requirements for dry ice removal prior to return. For Life Sciences customers requiring ultra-cold transport applications.
  • AR1000 Reusable cryogenic dry vapor shipper utilized primarily in veterinary and human assisted reproduction markets, capable of maintaining temperatures below -150°C for up to 10 days. Priced from $685 to $1,095 per unit.
  • DG1000 Reusable cryogenic shipper designed for shipping biological materials classified as dangerous goods by IATA standards, IATA certified for shipment of Class 6.2 Dangerous Goods under Packing Instruction 602. Priced from $685 to $1,095 per unit.
  • DS650 Reusable cryogenic shipper for shipment of specimens for diagnosis, treatment or evaluation of disease, conforming to IATA Packing Instruction 650 packaging standards. Priced from $685 to $1,095 per unit.
  • Shipper Unit Leasing Services Cycle Fee-based leasing of Cryoport shipper units with Standard Cycles of 15 days. Customers pay lease rate fees per Standard Cycle, with additional Cycle Fees for units not returned within the Standard Cycle and extended cycles available in 5-day increments at an additional 33.33% fee. For Life Sciences customers running clinical and commercial cryogenic logistics.
  • Biostorage and Sample Processing Biostorage and sample processing services provided through the CRYOGENE biorepository for the secure storage of biological research specimens and associated supplies. For research institutions, universities, and biopharmaceutical customers.

Quantifiable outcome

  • Maintain cryogenic temperatures of -150°C or less for up to 10 days (functional hold time in shipping use) and up to 16 days (maximum guaranteed under static conditions)

Companies that use Cryoport

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Cryoport technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Cryoport partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • CryoPort Systems Ltda.coreChannel Partner/ Reseller/ DistributorExclusive South American sales agent based in Sao Paulo, Brazil. Provides 17% commission for all sales in South American countries under a ten-year agreement expiring August 9, 2011.
  • LiquideminorChannel Partner/ Reseller/ DistributorThird-party reseller relationship for Cryoport products
  • SCA ThermosafeminorChannel Partner/ Reseller/ DistributorThird-party reseller relationship for Cryoport products

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Cryoport competitors and assessment

Company assessment

Emerging players

  • Vineti: Vineti provides a cloud-based platform for cell & gene therapy supply chain management, including chain of custody and patient scheduling. While focused on software rather than physical cryogenic logistics, it addresses similar cold chain orchestration challenges that Cryoport's Cryoportal.com platform targets.
  • Sartorius AG: Sartorius provides bioprocessing equipment and consumables for cell & gene therapy manufacturing, including some cryopreservation and cold chain-adjacent products. While primarily a bioprocessing-focused company, it offers storage and handling technologies that intersect with Cryoport's biopharma manufacturing services.
  • BioLife Solutions: BioLife Solutions provides biopreservation tools, cryopreservation media, and cold chain shipping products for the cell & gene therapy industry. While focused more on consumables and storage media than full-service logistics, it competes with Cryoport's CRYOGENE biorepository and adjacent cryopreservation offerings.

Direct peers

  • Azenta Life Sciences (formerly Brooks Life Sciences): Azenta provides biological sample storage, biorepository services, and cold chain logistics for the life sciences industry. Its sample management and biorepository offerings directly compete with Cryoport's CRYOGENE unit, and the company has expanded into temperature-controlled transport services.
  • Marken (UPS Healthcare): Marken is a global specialty courier for the life sciences industry, offering temperature-controlled and cryogenic logistics for clinical trials and cell & gene therapies. As a subsidiary of UPS Healthcare, it directly competes with Cryoport Systems in the same biopharma cold chain logistics market with comparable service offerings.
  • World Courier (Cencora): World Courier is a global specialty logistics provider serving the biopharmaceutical industry with temperature-controlled and cryogenic shipping capabilities. Owned by Cencora (formerly AmerisourceBergen), it competes directly with Cryoport Systems for clinical trial specimen transport and commercial therapy distribution.
  • QuickSTAT (a Kuehne+Nagel company): QuickSTAT is a global specialty courier specializing in time-sensitive and temperature-controlled logistics for clinical trials, biological samples, and cell therapies. Now part of Kuehne+Nagel, it competes directly with Cryoport in life sciences cold chain logistics with similar target customers.

Broad incumbents

  • Cytiva (Danaher): Cytiva is a global life sciences tools and bioprocessing provider owned by Danaher, offering products for cell therapy manufacturing including cryopreservation and cold storage solutions. As a broad incumbent, it competes with Cryoport's offerings to cell & gene therapy developers through its comprehensive bioprocessing portfolio.
  • Thermo Fisher Scientific: Thermo Fisher Scientific is a diversified life sciences tools and services giant offering cryogenic storage equipment through its laboratory products division. While it does not specialize in cryogenic logistics like Cryoport, it competes in adjacent product categories including biological storage systems and biopreservation consumables.

Regional players

  • Hyperion Logistics (formerly QuickSTAT competitor, Spanish pharma courier): Hyperion Logistics is a European specialty courier offering temperature-controlled and time-critical logistics for clinical trials and biopharmaceuticals. It competes with Cryoport in the EMEA region for life sciences cold chain services with comparable cryogenic handling capabilities.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Cryoport social profiles

Digital presence

Cryoport financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cryoport leadership team

Management profile

Number of profiles

Profiles7 records

Cryoport subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Cryoport funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cryoport M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cryoport

What does Cryoport do?

Cryoport, Inc. designs, manufactures, and leases temperature-controlled cryogenic shipping containers and storage systems for the Life Sciences industry through its Cryoport Systems, MVE Biological Solutions, and CRYOGENE business units. It also provides biostorage, sample processing, and temperature-controlled logistics support for biopharmaceutical, animal husbandry, and reproductive medicine customers, with cryogenic shippers that maintain temperatures of -150°C or below for 10-16 days and are IATA-certified for dangerous goods transport.

Is Cryoport a public or private company?

Cryoport is a public company. It is classified as public and is currently operating.

When was Cryoport founded?

Cryoport was founded in 1990. It employs 501 to 1,000 people.

Where is Cryoport based?

Cryoport is headquartered in Brentwood, United States, in the North America region.

How does Cryoport make money?

Three revenue lines are on record. Cryogenic Shipping Container Sales are the primary driver. The others are shipper Unit Leasing Services and biostorage and Sample Processing.

Who are Cryoport's main competitors?

Emerging players on record are Vineti, Sartorius AG and BioLife Solutions. Direct peers are Azenta Life Sciences (formerly Brooks Life Sciences), Marken (UPS Healthcare), World Courier (Cencora) and QuickSTAT (a Kuehne+Nagel company). Broad incumbents are Cytiva (Danaher) and Thermo Fisher Scientific. Hyperion Logistics (formerly QuickSTAT competitor, Spanish pharma courier) is listed as a regional player.

Does Cryoport have an API?

No public API is recorded for Cryoport.

What industry is Cryoport in?

Cryoport's product category is Cryogenic Life Sciences Logistics and Storage. Its primary akta.pro industry code is HLAGAGAK, Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low), with a secondary code of HLAGAMAB, Cryogenic Logistics (LN2 Dry Shippers, -150°C). Its NAICS code is 333415 and its SIC code is 3585.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales